Ikena Oncology Dirección
Dirección controles de criterios 2/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Mark Manfredi
Chief Executive Officer (CEO)
US$1.2m
Compensación total
| Porcentaje del salario del CEO | 45.9% |
| Permanencia del CEO | 6.3yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 1.3yrs |
| Promedio de permanencia en la Junta Directiva | 3.4yrs |
Actualizaciones recientes de la dirección
Recent updates
Growth Investors: Industry Analysts Just Upgraded Their Ikena Oncology, Inc. (NASDAQ:IKNA) Revenue Forecasts By 31%
Nov 10
Analysts Just Slashed Their Ikena Oncology, Inc. (NASDAQ:IKNA) EPS Numbers
Aug 15Need To Know: Analysts Are Much More Bullish On Ikena Oncology, Inc. (NASDAQ:IKNA) Revenues
May 20Will Ikena Oncology (NASDAQ:IKNA) Spend Its Cash Wisely?
Apr 29We Think Ikena Oncology (NASDAQ:IKNA) Needs To Drive Business Growth Carefully
Jan 06Companies Like Ikena Oncology (NASDAQ:IKNA) Are In A Position To Invest In Growth
Aug 06Party Time: Brokers Just Made Major Increases To Their Ikena Oncology, Inc. (NASDAQ:IKNA) Earnings Forecasts
Mar 23Ikena Oncology, Inc. (NASDAQ:IKNA) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
Mar 21Is Ikena Oncology (NASDAQ:IKNA) In A Good Position To Deliver On Growth Plans?
Feb 19We're Not Very Worried About Ikena Oncology's (NASDAQ:IKNA) Cash Burn Rate
Nov 02Ikena Oncology (NASDAQ:IKNA) Is In A Good Position To Deliver On Growth Plans
Jul 13Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | US$1m | US$569k | -US$68m |
| Sep 30 2023 | n/a | n/a | -US$63m |
| Jun 30 2023 | n/a | n/a | -US$63m |
| Mar 31 2023 | n/a | n/a | -US$66m |
| Dec 31 2022 | US$2m | US$546k | -US$69m |
| Sep 30 2022 | n/a | n/a | -US$52m |
| Jun 30 2022 | n/a | n/a | -US$49m |
| Mar 31 2022 | n/a | n/a | -US$41m |
| Dec 31 2021 | US$5m | US$530k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$63m |
| Jun 30 2021 | n/a | n/a | -US$55m |
| Mar 31 2021 | n/a | n/a | -US$47m |
| Dec 31 2020 | US$606k | US$410k | -US$44m |
Compensación vs. Mercado: La compensación total de Mark($USD2.46M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD667.11K).
Compensación vs. Ingresos: La compensación de Mark ha sido consistente con los resultados de la empresa en el último año.
CEO
Mark Manfredi (52 yo)
6.3yrs
Permanencia
US$1,240,640
Compensación
Dr. Mark Manfredi, Ph D., serves as Member of Scientific Advisory Board of Bantam Pharmaceutical, LLC. He has been President, Chief Executive Officer and Director of Ikena Oncology, Inc. since December 201...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.3yrs | US$1.24m | sin datos | |
| CFO & Head of Corporate Development | 2yrs | US$782.32k | 0% $ 0 | |
| Senior Vice President of Finance & Operations | 1.3yrs | sin datos | sin datos | |
| VP & Deputy General Counsel | less than a year | sin datos | sin datos | |
| Head of Human Resources | 2.8yrs | sin datos | sin datos | |
| Chief Development Officer | 2.4yrs | sin datos | sin datos | |
| VP & Head of Quality | 1.3yrs | sin datos | sin datos | |
| Senior Vice President of Clinical Development Operations | less than a year | sin datos | sin datos | |
| Chief Medical Officer | less than a year | sin datos | sin datos | |
| Senior Vice President of Technical Operations | less than a year | sin datos | sin datos |
1.3yrs
Permanencia media
51.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de IKNA no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 6.3yrs | US$1.24m | sin datos | |
| Independent Director | 8.1yrs | US$130.36k | 0.041% $ 25.4k | |
| Chair of Scientific Advisory Board | 3.4yrs | sin datos | sin datos | |
| Independent Director | 3.3yrs | US$128.25k | 0.041% $ 25.4k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.4yrs | sin datos | sin datos | |
| Chairman of the Board | 1.3yrs | US$167.86k | sin datos | |
| Independent Director | 8.1yrs | US$131.86k | 0.041% $ 25.4k | |
| Independent Director | 7.4yrs | US$126.97k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$117.86k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.4yrs | sin datos | sin datos | |
| Independent Director | 3yrs | US$117.86k | 0% $ 0 |
3.4yrs
Permanencia media
61.5yo
Promedio de edad
Junta con experiencia: La junta directiva de IKNA se considera experimentada (3.4 años de antigüedad promedio).